Related Experiment Video
Updated: Aug 18, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction
1Dept. of Cardiology, Angiology and Pneumology, Heinrich-Heine-University Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
Insights
In hypertrophic cardiomyopathy (HCM), elevated collagen synthesis markers and increased collagenolysis inhibition indicate fibrosis, explaining diastolic dysfunction. This study measured serum markers to understand collagen metabolism in HCM patients.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Pathophysiology
Background:
- Hypertrophic cardiomyopathy (HCM) is a prevalent condition with diverse clinical presentations.
- Left ventricular hypertrophy and elevated intramyocardial collagen contribute to diastolic dysfunction in HCM.
Purpose of the Study:
- To investigate the hypothesis of impaired collagenolysis in patients with HCM.
- To measure serum markers of type-I collagen metabolism.
- To correlate these markers with echocardiographic parameters of diastolic function.
Main Methods:
- Serum levels of matrix metalloproteinase-1 (MMP-1), its inhibitor TIMP-1, and collagen type-I markers (PICP, ICTP) were measured in 26 HCM patients and 38 controls.
- Assays used included ELISA and RIA.
- Diastolic function was assessed using Doppler echocardiography.
Main Results:
- Elevated free TIMP-1 and PICP levels were observed in HCM patients compared to controls.
- Free MMP-1 was significantly lower in HCM patients.
- The MMP-1/TIMP-1 ratio was reduced in HCM, suggesting inhibited collagenolysis. PICP correlated with diastolic E/A ratio and septal thickness.
Conclusions:
- Increased serum PICP indicates heightened collagen synthesis in HCM.
- Elevated TIMP-1 and a reduced MMP-1/TIMP-1 ratio suggest inhibited collagenolysis and collagen accumulation (fibrosis).
- This collagen accumulation likely explains the passive diastolic dysfunction observed in HCM patients.
Objectives:
The hypothesis of impaired collagenolysis in patients with hypertrophic cardiomyopathy (HCM) was tested by measuring serum markers of type-I collagen metabolism. These markers were correlated with echocardiographic parameters of diastolic function.
Background:
HCM is a common disease in the adult population with a wide range of clinical manifestations. Left ventricular hypertrophy and increased intramyocardial collagen content are known to cause diastolic dysfunction in patients with HCM.
Methods:
In 26 patients with HCM and 38 control subjects (aged: 57+/-3 and 54+/-2 years, p=n.s.) serum levels of collagenolytic matrixmetalloproteinase-1 (MMP-1) and its inhibitor TIMP-1, the markers for collagen type-I synthesis (PICP) and degradation (ICTP) were determined by ELISA and RIA. Diastolic function were determined by Doppler echocardiography.
Results:
Free TIMP-1 was elevated in HCM compared to controls (216,78+/-9,89 vs 183.77+/-7.57 ng/ml ; p=0.006) as well as PICP (165.92+/-10.26 vs 114.57+/-6.38 mug/l; p<0.001). Free MMP-1 was significantly lower in HCM (1.13+/-0.20 vs 2.33+/-0.34; p=0.01). ICTP did not differ. The MMP-1/TIMP-1 ratio was significantly lower in HCM (0.006+/-0.001 vs 0.012+/-0.001, p=0.003). PICP correlated positively with diastolic E/A ratio (r=0.389; p=0.05) and septal thickness (r=0.484; p=0.01).
Conclusions:
Serum marker of collagen synthesis (PICP) is increased in patients with HCM. Increased marker for inhibition of collagenolysis (TIMP-1) and a disturbed balance of collagen synthesis and degradation (ratio) with a predominance of inhibition of collagenolysis indicates collagen accumulation (fibrosis), which explains passive diastolic dysfunction in patients with HCM.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
